Skip to the page

Data / Drug companies / Vamsi Labs Limited.

Vamsi Labs Limited.: 17 products in the FDA NDC directory, labeler code 66412

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Vamsi Labs Limited. (labeler code 66412) lists 17 products in the FDA National Drug Code Directory. By type: 17 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on May 11, 2026.

The request: Watch Vamsi Labs Limited. (FDA labeler code 66412): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
66412
Products in commercial distribution
17
Packages
106
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
2
Earliest marketing start
September 25, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding17100%

Products by type

TypeProductsShare
Bulk ingredients17100%

Dosage forms

Dosage formProductsShare
Powder17100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Haloperidol decanoate66412-0771PowderBulk ingredients for compoundingMay 11, 2026
Dexamethasone66412-0300PowderBulk ingredients for compoundingMay 11, 2026
Mometasone furoate66412-0686PowderBulk ingredients for compoundingJuly 15, 2025
Triamcinolone acetonide66412-0515PowderBulk ingredients for compoundingJuly 15, 2025
Albuterol sulfate66412-0770PowderBulk ingredients for compoundingJune 12, 2025
Loperamide hydrochloride66412-0362PowderBulk ingredients for compoundingJune 12, 2025
Cyproheptadine hydrochloride66412-0122PowderBulk ingredients for compoundingJune 12, 2025
Salmeterol xinafoate66412-0768PowderBulk ingredients for compoundingSeptember 25, 2023
Fluticasone furoate66412-0767PowderBulk ingredients for compoundingSeptember 25, 2023
Fenoterol hydrobromide66412-0766PowderBulk ingredients for compoundingSeptember 25, 2023
Fluticasone propionate66412-0679PowderBulk ingredients for compoundingSeptember 25, 2023
Formoterol fumarate66412-0204PowderBulk ingredients for compoundingSeptember 25, 2023
Haloperidol66412-0506PowderBulk ingredients for compoundingJanuary 5, 2021
Clenbuterol66412-0417PowderBulk ingredients for compoundingJanuary 5, 2021
Budesonide66412-0393PowderBulk ingredients for compoundingJanuary 5, 2021
Tiotropium bromide monohydrate66412-0761PowderBulk ingredients for compoundingApril 20, 2020
Ipratropium bromide66412-0753PowderBulk ingredients for compoundingSeptember 25, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.